GILEAD SCIENCES, INC.: summary

GILEAD SCIENCES, INC. reported 5 positions with a reported value of $1.46B in its 13F for Q3 2026. Compared with Q2 2026: 0 new positions, 0 exited.

Top positions

Explore SEC Filings Hub